© 2021 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Infographic: Biosimilar Interchangeability
The Center for Biosimilars Staff
The Center for Biosimilars Staff
The Biologics Prescribers Collaborative released its comment letter to the FDA on the agency’s Considerations in Demonstrating Interchangeability, and made 5 key requests.
The Biologics Prescribers Collaborative released its comment letter to the FDA on the agency’s Considerations in Demonstrating Interchangeability, and made 5 key requests of the agency. Read more about the BPC's comments to the FDA here.